For Austria
Emonta Pharma distributes Mutaflor, Mutaflor mite, Mutaflor Suspension and Yomogi in Austria.
Medicinal product distribution | Austria
Emonta Pharma is the Austrian distributor of Mutaflor, Mutaflor mite, Mutaflor Suspension and Yomogi. Ardeypharm GmbH in Germany is the marketing authorisation holder and manufacturer.
For gut health in Austria, Emonta Pharma brings the Mutaflor product family and Yomogi by Ardeypharm to the Austrian market with personal local support.
As the Austrian distribution company, Emonta Pharma combines local market proximity with Ardeypharm's pharmaceutical experience. Ardeypharm in Germany is the marketing authorisation holder and manufacturer of the medicines.
Emonta Pharma distributes Mutaflor, Mutaflor mite, Mutaflor Suspension and Yomogi in Austria.
Ardeypharm in Germany is the marketing authorisation holder and manufacturer of the medicines.
Medicines & service
With Mutaflor, Mutaflor mite, Mutaflor Suspension and Yomogi, Emonta Pharma offers a focused gut-health portfolio in Austria and combines established medicines with personal local support.
The established medicine containing E. coli strain Nissle 1917 is a central part of Emonta's Austrian portfolio.
Mutaflor mite complements the Mutaflor product family for the Austrian market.
The liquid dosage form expands the Mutaflor product family in Austria.
The medicine containing Saccharomyces boulardii is part of Emonta Pharma's Austrian distribution portfolio.
Emonta.at provides information about the Mutaflor product family and Yomogi as well as direct contact details for Emonta Pharma.